Compare MMYT & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MMYT | INDV |
|---|---|---|
| Founded | 2000 | N/A |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.4B |
| IPO Year | 2010 | 2014 |
| Metric | MMYT | INDV |
|---|---|---|
| Price | $46.23 | $39.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $101.00 | N/A |
| AVG Volume (30 Days) | 997.2K | ★ 1.6M |
| Earning Date | 05-20-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 0.69 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $16.83 | N/A |
| Revenue Next Year | $17.24 | N/A |
| P/E Ratio | $107.67 | ★ $57.91 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $32.67 | $13.47 |
| 52 Week High | $104.99 | $41.00 |
| Indicator | MMYT | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 55.10 | 65.83 |
| Support Level | $44.66 | $35.36 |
| Resistance Level | $50.14 | $41.00 |
| Average True Range (ATR) | 2.80 | 1.28 |
| MACD | 0.43 | 0.12 |
| Stochastic Oscillator | 68.54 | 97.52 |
MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).